Dario selected to provide integrated and proven solutions to
improve employee cardiometabolic health
NEW
YORK, April 18, 2024 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced today two new contracts to
provide integrated chronic condition management solutions for two
employers beginning in the second quarter of 2024.
The employers, a national supply chain company and a regional
education organization, selected Dario's cardiometabolic suite to
help improve outcomes for employees with cardiometabolic health
conditions, including diabetes, pre-diabetes, hypertension and
weight management needs, including support for individuals taking a
GLP-1 medication.
Dario combines intelligent technologies with billions of data
insights gathered from a decade of consumer engagement to deliver
highly personalized experiences that keep members engaged over time
for optimal results. Employees enrolled in Dario's cardiometabolic
solution who are taking a GLP-1 medication will also have access to
a tailored experience to support long-term behavior change.
"The trend towards integrated solutions continues to grow as
employers look to reduce point solutions in favor of a single
integrated solution that has a better member experience and has a
lower cost of ownership when compared to managing multiple point
solutions. Our new accounts are excited about Dario's proven
ability to effectively engage people across multiple related
conditions, and we look forward to delivering the market-leading
results our clients deserve," said Rick
Anderson, President of Dario.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the expected timing of the launch of the solutions
and the benefits that may be realized by members using Dario's
solutions. Without limiting the generality of the foregoing,
words such as "plan," "project," "potential," "seek," "may,"
"will," "expect," "believe," "anticipate," "intend," "could,"
"estimate" or "continue" are intended to identify forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™ as described herein) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Media Contact
Scott Stachowiak
Scott.Stachowiak@russopartnersllc.com
+1-646-942-5630
Logo:
https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dario-signs-two-employers-for-cardiometabolic-suite-with-integrated-glp-1-solution-302120847.html
SOURCE DarioHealth Corp.
